20( R )‐ginsenoside Rg3 Inhibits Neuroinflammation Induced by Cerebral Ischemia/Reperfusion Injury by Regulating the Toll‐Like Receptor 4/Myeloid Differentiation Factor‐88/Nuclear Factor Kappa B Signaling Pathway
Chemistry & Biodiversity · 2025-12 · 22 (12)
DOI: 10.1002/cbdv.202500277 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, online erschienen am 09.09.2025. Verfasst von Dai-Ju Tao und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Science, Yunnan Key Laboratory of Pharmacology for Natural Products/College of Modern Biomedical Industry, NHC Key Laborator…. Hauptthemen laut MEDLINE: Ginsenosides, Reperfusion Injury, NF-kappa B, Signal Transduction. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
20( R )‐ginsenoside Rg3 can reduce the effects of oxidative stress and cell death in cerebral ischemia‒reperfusion injury (CIRI). Neuroinflammation is crucial post‐CIRI, but how 20( R )‐Rg3 affects ischemia‒reperfusion‐induced neuroinflammation is unclear. To study 20( R )‐Rg3's effects on neuroinflammation and neuronal preservation in stroke models and explore toll‐like receptor 4/myeloid differentiation factor‐88/nuclear factor kappa B (TLR4/MyD88/NF‐κB) pathway mechanisms. Middle cerebral artery occlusion/reperfusion (MCAO/R) rats and oxygen–glucose deprivation/reoxygenation (OGD/R)‐induced neuron injury were treated with 20( R )‐Rg3; survival, cytokine levels, and pathway protein expressions were assessed; efficacy with the TLR4 inhibitor was also evaluated. In MCAO/R rats, 20( R )‐Rg3 administration reduced inflammatory damage to brain tissue. 20( R )‐Rg3 dose‐dependently improved neuronal survival and attenuated inflammatory processes in OGD/R neurons. The expression levels of TLR4, MyD88, and phosphorylated NF‐κB p65 are upregulated in MCAO/R rat brain tissue and OGD/R‐induced neurons, and these effects are reversed by 20( R )‐Rg3 treatment. In addition, 20( R )‐Rg3 enhanced the anti‐inflammatory efficacy of the TLR4 inhibitor TAK‐242 and reduced inflammation in OGD/R‐exposed neurons. 20( R )‐Rg3 attenuates neuroinflammation and protects neurons via inhibiting TLR4/MyD88/NF‐κB pathway in vitro and in vivo, suggesting it is a potential therapeutic for ischemic stroke.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmaceutical Science, Yunnan Key Laboratory of Pharmacology for Natural Products/College of Modern Biomedical Industry, NHC Key Laboratory of Drug Addiction Medicine, Kunming Medical University, Kunming, P.…
- The Affiliated Qingyuan Hospital (Qingyuan People's Hospital), Guangzhou Medical University, Qingyuan, P. R. China.
- Department of Pharmacology, Haiyuan College, Kunming Medical University, Kunming, P. R. China.
ORCID-Profile: Bo He
Zitieren
APA
Tao, D. J., Li, R., Teng, J., Yang, Y., Zhang, L., Zhang, X., Yang, R. H., Su, H. Y., Shen, Z. Q., Chen, P., & He, B. (2025). 20( R )‐ginsenoside Rg3 Inhibits Neuroinflammation Induced by Cerebral Ischemia/Reperfusion Injury by Regulating the Toll‐Like Receptor 4/Myeloid Differentiation Factor‐88/Nuclear Factor Kappa B Signaling Pathway. Chemistry & Biodiversity, 22(12). https://doi.org/10.1002/cbdv.202500277
Vancouver
Tao DJ, Li R, Teng J, Yang Y, Zhang L, Zhang X, et al. 20( R )‐ginsenoside Rg3 Inhibits Neuroinflammation Induced by Cerebral Ischemia/Reperfusion Injury by Regulating the Toll‐Like Receptor 4/Myeloid Differentiation Factor‐88/Nuclear Factor Kappa B Signaling Pathway. Chemistry & Biodiversity. 2025;22(12). doi:10.1002/cbdv.202500277
BibTeX
@article{Tao2025,
author = {Tao, Dai-Ju and Li, Rui and Teng, Jia and Yang, Yuan and Zhang, Li and Zhang, Xiaochao and Yang, Ren-Hua and Su, Hai-Yu and Shen, Zhi-Qiang and Chen, Peng and He, Bo},
title = {20( R )‐ginsenoside Rg3 Inhibits Neuroinflammation Induced by Cerebral Ischemia/Reperfusion Injury by Regulating the Toll‐Like Receptor 4/Myeloid Differentiation Factor‐88/Nuclear Factor Kappa B Signaling Pathway},
journal = {Chemistry & Biodiversity},
year = {2025},
volume = {22},
number = {12},
doi = {10.1002/cbdv.202500277}
}
EUVIMED